Category - New Drugs
FDA Approves Motegrity (prucalopride) for Adults with Chronic Idiopathic Constipation (CIC)
FDA Approves Nplate (Romiplostim) For Use In Pediatric Patients With Immune Thrombocytopenia
FDA Approves Herzuma (trastuzumab-pkrb), a Biosimilar to Herceptin
FDA Approves Tolsura (SUBA®-itraconazole capsules) for the Treatment of Certain Fungal Infections
FDA Approves Genentech’s Tecentriq in Combination With Avastin and Chemotherapy for the Initial Treatment of Metastatic Non-Squamous Non-Small Cell Lung Cancer
FDA Approves Dextenza (dexamethasone ophthalmic insert) for the Treatment of Ocular Pain Following Ophthalmic Surgery
FDA Approves Firdapse (amifampridine) for Lambert-Eaton Myasthenic Syndrome
FDA Approves Xospata (gilteritinib) for Acute Myeloid Leukemia (AML) with a FLT3 Mutation